Tuesday, July 17, 2018

Roche said on Tuesday its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications from flu, a boost to the Swiss drugmaker's efforts to win approval for the single-dose, oral anti-viral medicine.


from Reuters: Health News https://ift.tt/2zMGpP8

Related Posts:

  • LATEST HEALTH NEWS(Reuters Health) - Standing above the crowd puts people at greater risk of developing varicose veins, a large genetic study suggests. from Reuters: Health News https://ift.tt/2RyaN3K … Read More
  • LATEST HEALTH NEWS(This Oct 31 story corrects paragraph one to say targeted therapy, not immunotherapy) from Reuters: Health News https://ift.tt/2ADJhvU … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Teens seeking to buy emergency contraception at pharmacies continue to face significant roadblocks, a new U.S. study suggests. from Reuters: Health News https://ift.tt/2PEljsK … Read More
  • LATEST HEALTH NEWSTrevena Inc shares plunged 45 percent on Friday after the U.S. Food and Drug Administration declined to approve its opioid injection for managing acute pain, citing inadequate safety data. from Reuters: Health News https… Read More
  • LATEST HEALTH NEWSThe U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner